What are the side effects of Abilify (aripiprazole) in a 14‑year‑old?

Abilify Side Effects in a 14-Year-Old

In a 14-year-old, Abilify (aripiprazole) carries significant risks including weight gain, sedation, extrapyramidal symptoms (muscle stiffness, tremor, restlessness), metabolic changes, and potentially serious neurological complications—all of which require close monitoring given that adolescents may have difficulty recognizing and communicating these side effects. 1

Most Common Side Effects to Expect

The FDA label and clinical evidence identify these as the most frequently occurring side effects in adolescents 1:

Neurological/Movement Effects

• Extrapyramidal symptoms (muscle stiffness, abnormal movements) - occurs in up to 20% of adolescents
• Akathisia (severe inner restlessness, inability to sit still) - 10-13% incidence
• Tremor - 6-10% incidence
• Sedation/somnolence - 10-23% depending on indication
• Headache (common but usually mild)

Metabolic/Physical Effects

• Weight gain - one of the most common and significant problems 2
• Fatigue (11-17% in adolescents)
• Increased appetite or decreased appetite
• Nausea and vomiting (11-14%)

Other Common Effects

• Increased salivation/drooling (6-9%)
• Blurred vision (8%)
• Insomnia despite sedation in some patients
• Dizziness (5%)

Serious Side Effects Requiring Immediate Attention

Youth are at higher risk than adults for certain serious complications 2:

Neuroleptic Malignant Syndrome (NMS)

• Life-threatening condition with high fever, severe muscle rigidity, confusion, unstable vital signs
• Requires immediate discontinuation and emergency care 1

Tardive Dyskinesia

• Involuntary movements of face, tongue, or body that may become permanent
• Can occur even after stopping the medication 1
• Adolescents may be at higher risk for movement disorders than adults 2

Metabolic Complications

• Hyperglycemia and diabetes risk - monitor blood sugar, especially with family history of diabetes
• Elevated cholesterol and triglycerides
• Extreme weight gain that can be severe 2

Cardiac Effects

• QT prolongation on ECG - youth may be more susceptible to cardiac effects 2
• Orthostatic hypotension (dizziness when standing)
• One case report documented prolonged QRS widening in a 14-year-old after overdose 3

Psychiatric/Behavioral

• Suicidal behavior - reported in 14.9% of psychiatric adverse events in pediatric surveillance data 4
• Severe insomnia (paradoxically, despite sedation)
• Behavioral changes, increased agitation 5

Critical Monitoring Requirements

Because adolescents may have difficulty recognizing and communicating side effects due to developmental issues, particularly close monitoring is essential 2:

Baseline Before Starting

• Weight, height, BMI
• Blood glucose and lipid panel (especially if diabetes risk factors)
• Blood pressure
• Liver function tests (prudent given case reports of elevations) 2
• ECG if cardiac risk factors present

Ongoing Monitoring

• Weekly visits initially to establish rapport and ensure compliance 2
• Weight checks at every visit - weight gain can be extreme 2
• Movement disorder assessment at each visit (watch for stiffness, tremor, restlessness, abnormal movements)
• Blood glucose and lipids periodically during treatment
• Blood pressure monitoring
• Assess for behavioral changes, mood shifts, suicidal ideation

Important Clinical Pitfalls

Akathisia Misinterpretation

Akathisia (severe restlessness) is commonly mistaken for psychotic agitation or anxiety and is a major reason for medication non-compliance 2. Look for pacing, inability to sit still, inner sense of restlessness. This is difficult to treat and may require dose reduction.

Delayed Recognition in Intellectually Disabled Youth

Extrapyramidal side effects can be insidious and non-specific (poor mobility, increased drooling) in patients with intellectual disabilities, leading to delayed recognition 6. These side effects can develop years after treatment initiation, requiring ongoing vigilance.

Cognitive vs. Disease Effects

Differentiating between medication-induced cognitive blunting/sedation and negative symptoms of the underlying psychiatric condition can be challenging 2.

Off-Label Use Concerns

Real-world data shows high rates of use for non-authorized indications in children, with approximately 90% of reported adverse events being serious 4. The benefit-risk ratio remains poorly defined for many pediatric uses.

Rare but Documented Effects

• Enuresis (bedwetting) - rare but reported even at low doses 7
• Agranulocytosis (severe white blood cell drop) - though primarily associated with clozapine, can occur with any antipsychotic 2
• Hepatic enzyme elevations 2
• Seizures (lower risk than with clozapine)
• Unusual urges (gambling, compulsive eating, hypersexuality) 1

Context from Guidelines

The American Academy of Child and Adolescent Psychiatry emphasizes that antipsychotic medications in youth have not been well studied, and children may have significant side effects that are yet unrecognized 2. Side effects are a common reason for non-compliance, which increases relapse risk and morbidity. Despite these concerns, atypical antipsychotics like aripiprazole are considered standard-of-care for many pediatric psychiatric conditions due to their generally more favorable profile compared to traditional antipsychotics 2.